Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: a retrospective analysis

BACKGROUND: Most cancer drugs enter the US market first. US Food and Drug Administration (FDA) approvals of new cancer drugs may influence regulatory decisions in other settings. The study examined whether characteristics of available evidence at FDA approval influenced time-to-marketing authorisati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ivama-Brummell, Adriana M., Marciniuk, Fernanda L., Wagner, Anita K., Osorio-de-Castro, Claudia G.S., Vogler, Sabine, Mossialos, Elias, Tavares-de-Andrade, Carla L., Naci, Huseyin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206192/
https://www.ncbi.nlm.nih.gov/pubmed/37235087
http://dx.doi.org/10.1016/j.lana.2023.100506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206192/
https://www.ncbi.nlm.nih.gov/pubmed/37235087
http://dx.doi.org/10.1016/j.lana.2023.100506

Ejemplares similares